Skip to main content
Caplight Logo









Sperogenix Therapeutics

Sperogenix Therapeutics

Private
BeijingHealthcare & Life Scienceshttps://sperogenix.com/

Last Round

Series B

Oct 23, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sperogenix Therapeutics is a pharmaceutical company that develops and commercializes rare disease therapeutics in China.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

rare disease therapeuticsbiopharmaceuticalin-licensingDuchenne muscular dystrophyDMDvamoroloneorphan drugsclinical developmentregulatory navigationbiotech licensingneuromuscular disordersmetabolic disordersdrug commercializationX-linked adrenoleukodystrophyX-ALD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sperogenix Therapeutics Comparables

Compare Sperogenix Therapeutics with similar companies based on industry and business-model similarity.

Sperogenix Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CS Pharmaceuticals
78%
Hongkong Winhealth Pharma Group
78%
CANbridge Pharma
72%

Sperogenix Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 23, 2023

Key People

Founding team and executive leadership

Alan Yan

Co-founder & CEO

Founding Team

Sperogenix Therapeutics Investors

Notable investors and investment history

Sperogenix Therapeutics investors
InvestorRounds
Morningside VenturesSeries A
Jingxu Venture CapitalSeries A
Lilly Asia VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 695% MoM, from 255 to 2K.

  • Jul 1, 2025

    Monthly visitors increased 138% MoM.

Sperogenix Therapeutics Filings

Explore SEC and related filing metadata, where available.

Sperogenix Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sperogenix Therapeutics's valuation, stock price, and market status.

Is Sperogenix Therapeutics a public or private company?

Sperogenix Therapeutics is a private company.

What is the current stock price of Sperogenix Therapeutics?

Sperogenix Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Sperogenix Therapeutics worth (valuation)?

Valuation information for Sperogenix Therapeutics is not publicly available.

Can I buy Sperogenix Therapeutics stock?

Sperogenix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sperogenix Therapeutics's last funding round?

Funding round information for Sperogenix Therapeutics is not publicly available.

Who are the main investors in Sperogenix Therapeutics?

Investor information for Sperogenix Therapeutics is not publicly disclosed.

Will Sperogenix Therapeutics IPO soon?

No public IPO plans have been announced for Sperogenix Therapeutics.

How can I track Sperogenix Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sperogenix Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range15
Year Founded2019
Last FundingOct 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?